Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies
Rheumatology (Oxford)
.
2020 Apr 1;59(4):917.
doi: 10.1093/rheumatology/kez609.
Authors
Maria K Kvamme
1
2
3
,
Elisabeth Lie
1
,
Till Uhlig
1
,
Tron A Moger
2
,
Tore K Kvien
1
,
Ivar S Kristiansen
2
Affiliations
1
Department of Rheumatology, Diakonhjemmet Hospital.
2
Department of Health Management and Health Economics, University of Oslo.
3
Norwegian Knowledge Centre for the Health Services, Oslo, Norway.
PMID:
31865376
DOI:
10.1093/rheumatology/kez609
No abstract available
Publication types
Published Erratum